Insulin-like growth factor-I (IGF-I) promotes normal and adaptive growth of the small intestine and colon. Despite these beneficial actions, IGF-I is implicated as a mediator of intestinal tumorigenesis and is a potent inhibitor of crypt apoptosis. This proposal aims to examine intrinsic mechanisms which may limit the tumorigenic potential of IGF-I in the normal intestine while favoring normal growth and differentiation. Specifically we will test the hypothesis that low levels of IRS-1 favor increased apoptosis and high levels of SOSC2 favor normal growth and differentiation. Studies will use a model of irradiation induced apoptosis and cell cycle arrest, in vitro stem cell assays, model intestinal epithelial cell lines and mice with targeted deletion of key genes implicated in regulating IGF-I action.
Aim 1 will test the hypothesis that partial or absolute IRS-1 deficiency impairs survival of normal or genetically damaged crypt stem cells and limits the anti-apoptotic actions of IGF-I in vivo and in vitro. Crypt apoptosis will be examined in non-irradiated and irradiated mice with 2,1, or 0 copies of the IRS-1 gene, and IRS-1 null and WT given vehicle or IGF-I. Clonogenic assays on isolated crypt epithelial cells from mice with 2.1 or 0 copies of IRS-1 will test directly whether there is a dose dependent requirement for IRS-1 as a mediator of survival or clonal growth of crypt stem cells or IGF-I action on stem cell survival. Known mediators of IRS-1/IGF-I action in cell lines will be quantified by assays on tissue extracts and isolated crypts and by immunohistochemistry. This will provide novel information about the in vivo mediators of IGF-I/IRS-1 action on crypt epithelial cells and define if IRS-1/IGF-I dependent changes in mediators occur selectively or preferentially in crypt stem cells.
Aims 2 and 3 will test the hypothesis that suppressor of cytokine signaling-2 (SOCS2) limits the proliferative actions of IGF-I on intestinal epithelial cells and promotes enterocyte differentiation. Caco2 cells, HT-29 cells and IEC-6 cells transfected with SOCS2 antisense or sense expression constructs will be used to define the mechanisms by which SOCS2 reduces IGF-I dependent proliferation, promotes differentiated function and to assess if SOCS2 affects apoptosis. Mice with targeted disruption of one or both SOCS2 alleles and wild type littermates will be used to define the in vivo role of SOCS2 in post-natal growth and maturation of the intestine and test directly if SOCS2 limits the proliferative or anti-apoptotic actions of IGF-I in intestine in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK040247-14
Application #
6911629
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
May, Michael K
Project Start
1989-05-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2007-06-30
Support Year
14
Fiscal Year
2005
Total Cost
$327,448
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Physiology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Kechele, Daniel O; Blue, R Eric; Zwarycz, Bailey et al. (2017) Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest 127:593-607
Andres, Sarah F; Santoro, M Agostina; Mah, Amanda T et al. (2015) Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs. Am J Physiol Gastrointest Liver Physiol 308:G100-11
Van Landeghem, Laurianne; Santoro, M Agostina; Mah, Amanda T et al. (2015) IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations. FASEB J 29:2828-42
Poindexter, Shenika V; Reddy, Vishruth K; Mittal, Mukul K et al. (2015) Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury. Am J Physiol Gastrointest Liver Physiol 308:G562-71
Santoro, M Agostina; Blue, R Eric; Andres, Sarah F et al. (2015) Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon. Am J Physiol Gastrointest Liver Physiol 309:G578-89
Mah, Amanda T; Van Landeghem, Laurianne; Gavin, Hannah E et al. (2014) Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1. Endocrinology 155:3302-14
Santoro, M Agostina; Andres, Sarah F; Galanko, Joseph A et al. (2014) Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 23:2093-100
Andres, Sarah F; Simmons, James G; Mah, Amanda T et al. (2013) Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation. J Cell Sci 126:5645-56
Hamilton, Kathryn E; Tétreault, Marie-Pier; Lund, P Kay (2013) Opportunities and challenges for women PhD investigators in gastrointestinal research. Gastroenterology 145:266-71
Van Landeghem, Laurianne; Santoro, M Agostina; Krebs, Adrienne E et al. (2012) Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. Am J Physiol Gastrointest Liver Physiol 302:G1111-32

Showing the most recent 10 out of 45 publications